Form 8-K - Current report:
SEC Accession No. 0001213900-24-061521
Filing Date
2024-07-16
Accepted
2024-07-16 06:11:30
Documents
15
Period of Report
2024-07-15
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209474-8k_masimo.htm   iXBRL 8-K 43923
2 PRESS RELEASE, DATED JULY 16, 2024 ea020947401ex99-1_masimo.htm EX-99.1 23079
3 GRAPHIC image_001.jpg GRAPHIC 10021
  Complete submission text file 0001213900-24-061521.txt   278770

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE masi-20240715.xsd EX-101.SCH 3009
5 XBRL LABEL FILE masi-20240715_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE masi-20240715_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209474-8k_masimo_htm.xml XML 3539
Mailing Address 52 DISCOVERY IRVINE CA 92618
Business Address 52 DISCOVERY IRVINE CA 92618 949-297-7000
MASIMO CORP (Filer) CIK: 0000937556 (see all company filings)

EIN.: 330368882 | State of Incorp.: DE | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-33642 | Film No.: 241118548
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)